Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research
Share Article
The Drug Enforcement Administration green lights Psilera’s mission to study new DMT and psilocybin treatments for central nervous system disorders
We are focused on novel delivery mechanisms to harness neurological benefits while making these treatments more accessible to patients in need. TAMPA, Fla. (PRWEB) February 25, 2021
Psilera Bioscience (“Psilera”) in collaboration with the University of South Florida (“USF”) and its Chemical Purification and Screening facility has received DEA approval to research DMT, psilocybin, and psilocin (the active ingredients naturally found in ayahuasca tea and magic mushrooms).
Psilera and USF join only a handful of prestigious U.S. universities to undertake psychedelics research. Psilera will initiate research programs in its quest to become the first psychedelics co